Amendment to the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002
8. For regulation 16(2)(a) (applications for consent to market), substitute—
“(a)the information prescribed in Part 2 of schedule 2, where the application is for consent to market any genetically modified higher plant, or schedule 3 in any other case, to the extent that such information is—
(i)appropriate to the nature and scale of the release or application, and
(ii)in the case of schedule 2, relevant and necessary for the purposes of the environmental risk assessment referred to in sub-paragraph (c), in view especially of the characteristics of the genetically modified organism and of the scale and conditions of the release or of its intended conditions of use,
(aa)where the application is for consent to market a genetically modified higher plant, summaries and results of studies referred to in the application for consent to market, including an explanation of their relevance to the environmental risk assessment referred to in sub-paragraph (c), where applicable,
(ab)where the application is for consent to market a genetically modified higher plant, detailed information on the studies referred to in the application for consent to market, including—
(i)a description of the methods and materials used or the reference to standardised or internationally recognised methods, and
(ii)the name of the body or bodies responsible for carrying out the studies,”.